Stick With Invesco Ltd (IVZ). The Bull Are Alive And Well

Currently, there are 449.50M common shares owned by the public and among those 439.72M shares have been available to trade.

The company’s stock has a 5-day price change of 2.94% and -7.68% over the past three months. IVZ shares are trading -7.68% year to date (YTD), with the 12-month market performance up to 2.23% higher. It has a 12-month low price of $12.48 and touched a high of $18.71 over the same period. IVZ has an average intraday trading volume of 4.71 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.13%, 4.02%, and 5.50% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Institutional ownership of Invesco Ltd (NYSE: IVZ) shares accounts for 85.02% of the company’s 449.50M shares outstanding.

It has a market capitalization of $7.40B and a beta (3y monthly) value of 1.42. The earnings-per-share (ttm) stands at -$0.75. The company has a debt-to-equity ratio at 0.59. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.69% over the week and 2.21% over the month.

Analysts forecast that Invesco Ltd (IVZ) will achieve an EPS of $0.38 for the current quarter, $0.41 for the next quarter and $1.9 for 2025. The lowest estimate earnings-per-share for the quarter is $0.34 while analysts give the company a high EPS estimate of $0.41. Comparatively, EPS for the current quarter was $0.38 a year ago. Earnings per share for the fiscal year are expected to increase by 12.47%, and 11.44% over the next financial year.

Looking at the support for the IVZ, a number of firms have released research notes about the stock. TD Cowen stated their Outperform rating for the stock in a research note on January 04, 2024, with the firm’s price target at $21. Keefe Bruyette coverage for the Invesco Ltd (IVZ) stock in a research note released on December 14, 2023 offered a Outperform rating with a price target of $20. BMO Capital Markets was of a view on July 10, 2023 that the stock is Market Perform, while Citigroup gave the stock Neutral rating on May 19, 2023, issuing a price target of $16. Credit Suisse on their part issued Neutral rating on March 29, 2023.

Most Popular

Related Posts